- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02938351
Collaborative Care Intervention for Chronic Kidney Disease
May 3, 2021 updated by: Jennifer Steel, University of Pittsburgh
Collaborative Care Intervention for Kidney Transplant Patients
The aims of the present study will be to pilot test the efficacy of a collaborative care intervention in patients awaiting kidney transplant to reduce symptoms of depression, pain, fatigue and improve quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Symptom management is critical to maintain quality of life in those with life limiting conditions.
Stepped collaborative care interventions have been widely employed in the primary care setting for the treatment of depression and more recently have been utilized to treat other symptoms (e.g., pain) in a variety of settings.
A recent meta-analyses concluded that collaborative care interventions were superior to usual care and are more cost-effective than face to face and pharmacological treatment for depression.
Collaborative care interventions have begun to be extended to other settings but have not been tested in patients who are being treated with dialysis.
The aims of the present study were to pilot test the efficacy of a collaborative care intervention in patients awaiting kidney transplant to reduce symptoms of depression, pain, fatigue and improve quality of life.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Age 18 or older Currently receiving dialysis at UPMC dialysis facility for chronic kidney disease Fluent in English
Exclusion Criteria:
Under the age of 18 years or over 90 years Not fluent in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: collaborative care
To test the efficacy of a collaborative care intervention with patients treated with dialysis to reduce depression, pain, fatigue, and improve quality of life
|
Therapist will use iPad (Vidyo) once a week during dialysis for approximately one hour.
The therapist will teach the patient cognitive-behavioral strategies to manage their mood and pain.
The PI is a clinical psychologist and will provide supervision to the therapist providing the intervention.
The sessions for depression will include (1) intake, (2) review of the rational for using CBT to treat depression and/or pain, (3) identifying thought patterns, (4) changing thought patterns, (5) relaxation techniques, (6) rest-activity pacing, and (7) coping strategies.
Homework to practice these techniques will be provided after each session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression Level
Time Frame: change from baseline at 3 month and 6 month
|
score on CES-D questionnaire
|
change from baseline at 3 month and 6 month
|
Perceived Stress level
Time Frame: change from baseline at 3 month and 6 month
|
score on PSS questionnaire
|
change from baseline at 3 month and 6 month
|
degree of Pain
Time Frame: change from baseline at 3 month and 6 month
|
score on the BPI questionnaire
|
change from baseline at 3 month and 6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyadic functioning
Time Frame: change from baseline at 3 month and 6 month
|
score on the Dyadic functioning questionnaire
|
change from baseline at 3 month and 6 month
|
level of physical activity (mild, moderate or high)
Time Frame: change from baseline at 3 month and 6 month
|
calculated score on the International Physical Activity quationnaire
|
change from baseline at 3 month and 6 month
|
sleep quality
Time Frame: change from baseline at 3 month and 6 month
|
score on the PSQI questionnaire
|
change from baseline at 3 month and 6 month
|
quality of life
Time Frame: change from baseline at 3 month and 6 month
|
score on the KDQOL questionnaire
|
change from baseline at 3 month and 6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer Steel, PhD, University of Pittsburgh Physicians
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
December 7, 2019
Study Completion (Actual)
March 1, 2021
Study Registration Dates
First Submitted
January 5, 2016
First Submitted That Met QC Criteria
October 17, 2016
First Posted (Estimate)
October 19, 2016
Study Record Updates
Last Update Posted (Actual)
May 4, 2021
Last Update Submitted That Met QC Criteria
May 3, 2021
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO15110210
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Collaborative care
-
Boston Medical CenterCodman Square Health Center; Dorchester House Health CenterCompletedAttention Deficit/Hyperactivity DisorderUnited States
-
University of ArkansasCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepression | Generalized Anxiety Disorder | Panic DisorderUnited States
-
Seattle Children's HospitalCompletedDepression | Anxiety | TBI | Concussion, BrainUnited States
-
University of UtahRobert Wood Johnson FoundationCompletedChild Abuse | Primary Health Care | Child WelfareUnited States
-
University of WashingtonNational Institute on Disability, Independent Living, and Rehabilitation...CompletedChronic Pain | Brain Injuries, Traumatic | Post-Traumatic HeadacheUnited States
-
National University of SingaporeCompleted
-
Washington University School of MedicineAgency for Healthcare Research and Quality (AHRQ)CompletedDepression | Coronary Heart DiseaseUnited States
-
University of Puerto RicoNational Institute of General Medical Sciences (NIGMS)Completed
-
Seattle Children's HospitalNational Institute of Mental Health (NIMH); University of Washington; Kaiser...Completed